AU2001237794A1 - Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin - Google Patents
Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobinInfo
- Publication number
- AU2001237794A1 AU2001237794A1 AU2001237794A AU3779401A AU2001237794A1 AU 2001237794 A1 AU2001237794 A1 AU 2001237794A1 AU 2001237794 A AU2001237794 A AU 2001237794A AU 3779401 A AU3779401 A AU 3779401A AU 2001237794 A1 AU2001237794 A1 AU 2001237794A1
- Authority
- AU
- Australia
- Prior art keywords
- hydrophobin
- agent
- sulfhydryl
- protecting
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to a method of stabilizing a hydrophobin-containing solution. According to the present invention, the hydrophobin is subjected to a treatment with a disulphide bridge-cleaving agent to yield unfolded hydrophobin, said treatment involving the prevention of the formation of disulphide bridges from cleaved disulphide bridges. The invention also relates to a method for coating a surface with a stabilized hydrophobin according to the present invention.
Description
Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin
The present invention relates to a method of stabilizing a hydrophobin-containing solution.
Hydrophobin-containing solutions must be handled carefully, as even modest shaking may result in the assembly of the hydrophobin resulting in aggregates which affect the ability to coat a surface as well as the uniform coating of a surface to be coated with said hydrophobin.
It is known that 100% trifluoroacetic acid (TFA) can be used to dissolve the aggregates. After removal of TFA by ' evaporation using a stream of gas the hydrophobin monomers obtained are taken up in water and used for coating. It has been found that this procedure can be repeated several times and that TFA has no adverse effects on hydrophobin. However, TFA is not a compound to be used for environmental and safety reasons as well as cost.
The object of the present invention is to reduce or eliminate the above disadvantages.
To this end a method according to the preamble is provided characterized in that the hydrophobin is subjected to a treatment with a disulphide bridge-cleaving agent to yield unfolded hydrophobin, said treatment involving the prevention of the formation of disulphide bridges from cleaved disulphide bridges.
It has been found that using the above method, it is easy to prevent a hydrophobin-containing solution from becoming turbid while, for example, transporting or handling the hydrophobin-containing solution.
Hydrophobins are a well-defined class of proteins (ref. 1) capable of self-assembly at a hydrophobic- hydrophilic interface, and having a conserved sequence Xn-C-X5_9-C-C-X11_39-C-X8_23-C-X5_9-C-C-X6_18-C-Xm X, of course, represents any a ino acid, and ,n and m, of course, independently represent an integer. In general, a hydrophobin has a length of up to 125 amino acids. The cysteine residues (C) in the conserved sequence are part of
disulfide bridges. In the present invention, the term hydrophobin has a wider meaning to include functionally equivalent proteins, and encompasses a group of proteins comprising the sequence or parts thereof Λn-L-X: 50~C-X0-5-C-X1-]^0-C-Λ:j^100-C-Λ1..50-L-Λ0_5-C-Λ1_50-C-Λm still displaying the characteristic of self-assembly at a hydrophobic-hydrophilic interface resulting in a protein film. In accordance with the definition of the present invention, self-assembly can be detected by adsorbing the protein to Teflon and use Circular Dichroism to establish the presence of a secondary structure (in general ce-helix) (ref . 2) . The formation of a film can easily be established by incubating a Teflon sheet in the protein solution followed by at least three washes with water or .buffer (ref. 3) . The protein film can be visualised by any method, such as labeling with a fluorescent compound or by the use of fluorescent antibodies, as is well established in the art. m and n may have values ranging from 0 to 2000. Included in the definition are fusion-proteins of a hydrophobin and another protein. According to a first embodiment, the treatment consists of a treatment with sulphite, resulting in a modified hydrophobin carrying sulphite groups.
This method, which can be performed as described by Chan (ref. 6), results in a stabilized modified hydrophobin.' According to a second embodiment, the treatment, comprises the use of a reducing agent as the disulphide bridge cleaving agent, resulting in the modified hydrophobin carrying free sulfhydryl-groups .
Such sulfhydryl groups can be stabilized by one of several ways, for example using a sulfhydryl-protecting agent. Sulfhydryl-protecting agents, which are commercialy avialable, are agents capable of binding to the sulphur atom of a cystein residue, commonly by replacing the hydrogen atom of the sulfhydryl group. Accordingly, according to a pre- ferred embodiment, the prevention of the formation of disulphide bridges comprises reacting the reduced hydrophobin with a sulfhydryl-protecting agent yielding hydrophobin having sulfhydryl-protecting groups.
Preferably the sulfhydryl-protecting agent is a
protecting agent resulting in an ionic protecting group.
While sulfhydryl-protecting agents in general and a sulfhydryl-protecting agent resulting in a bulky protecting group in particular are thought to be suitable for the pur- pose of protecting sulfhydryl groups resulting from the reduction of disulphide bridges, a sulfhydryl-protecting agent resulting in an ionic group (present after the sulfhydryl group is protected) is considered best.
According to a highly preferred embodiment, the sulfhydryl-protecting agent is chosen to allow for removal of the sulfhydryl-protecting groups to yield free sulfhydryl residues.
The removal allows the stabilized hydrophobin-containing solution to be used for coating a surface with previ- ously stabilized hydrophobin, and may result in a coating which is more similar to a coating with untreated hydrophobin, with cystin residues being restored.
According to a preferred embodiment, the prevention of the formation of disulphide bridges comprises exposing the reduced hydrophobin to an environment in which substantially no oxidizing agent is present.
Absence of an oxidizing agent, including atmospheric or dissolved oxygen, helps to prevent the formation of disulphide bridges . According to a preferred embodiment the reduction is performed in the presence of an agent chosen from the group consisting of a) a surfactant; b) a chaotropic agent, such as urea.
The use of such an agent, more in particular a pro- tein unfolding-enhancing agent, facilitates the reduction of disulphide bridges present in hydrophobin.
Accordingly, the present invention relates to a method for coating a surface with a hydrophobin, characterized in that a stabilized hydrophobin-containing solution according to the present invention is used, wherein the stabilized solution is contacted with a surface to be coated with the hydrophobin before the surface is contacted with an agent for the formation of disulphide bridges, and sulfhydryl-protecting residues, if present, are removed.
According to an alternative embodiment, the present invention relates to a method of coating a surface with a hydrophobin, characterized in that a stabilized hydrophobin- containing solution according to the present invention is used, wherein in the absence of a gaseous phase i) sulfhydryl-protecting groups, if present, are removed and ii) the reduced hydrophobin is contacted with an agent in the liquid phase before, during or after contacting the reduced hydrophobin with the surface to be coated. Both these methods allow for the uniform coating of a surface without aggregates. Also, in both cases the agent is preferably an oxidizing agent.
Surprisingly it has been found that the presence of sulfhydryl-protecting groups does not impede the coating of a surface with a hydrophobin carrying said groups . The sulfhydryl-protecting groups may be removed at any time before, during or after the coated surface is contacted with the oxidizing agent.
The invention will now be illustrated with reference to the following example and the only figure which shows a
Circular Dichroism spectrum of a modified hydrophobin adsorbed to a Teflon surface.
PREPARATIONS
A) Purification of hydrophobin SC3 The hydrophobin SC3 was purified from the culture medium of strain 4-40 of Schizophyllum commune (CBS 340.81) as described (1, 4) . Before use, the freeze-dried SC3 was disassembled with pure TFA and dried in a stream of nitrogen. The monomeric protein was then dissolved in the buffer specified under B) , C) and D)
Bl) Carboxymethylation of SC3 with iodoacetic acid
Reduction of SC3 and carboxymethylation of the free cysteine residues were performed essentially as described by Hollecker (5) . 1 mg of SC3 as obtained under A) was incubated for 30 minutes in 0.5 ml buffer containing 75 mM Tris/HCl pH 8.0, 5.4 M Guanidine Hydrochloride, 2.5 mM EDTA and 1 mM DTT at 37°C. This was followed by adding 50 μl of 0.2 M iodoacetic acid (IAA) in 75 mM Tris pH 8.0 and incubating the mixture for 15 minutes at room temperature.
After reaction the sample was dialysed exhaustively against water and lyophilized, yielding IAA-SC3. Bl) Sulfytolysis of SC3
Sulfytolysis results in reduction of disulfide bridges, with the concommitant formation of S03 " groups, rendering the resulting protein derivative more soluble. The modification is a reversible modification. SC3 was sulfytolized essetially according Chan (ref. 6) . In short, 2 mg SC3 was incubated overnight in 2 ml of a buffer (pH 8.4; 0..2 M sodium sulphite, 0.1 M Tris, 6 M guanidine hydrochloride, and 1 mM cystein) for 16 h at room temperature (RT) . The reaction mixture was desalted using a Pharmacia PD-10 column. The reaction was checked using SDS-PAGE, which revealed a band at 28 kDa. After lyophilising, the result- ing S03-SC3 was used in refolding experiments. C) Secondary structure measurements
The secondary structure of the carboxymethylated SC3 was studied with circular dichroism spectroscopy (CD) . The CD- spectra were recorded over the wavelength region 190-250 nm on an Aviv 62A DS CD spectrometer (Aviv Associates,
Lakewood, Mew Jersey, USA), using a 1-mm quartz cuvette. The sample compartment was continuously flushed with N2 gas and the temperature was kept constant at 25°C. 10 scans were averaged, using a bandwidth of 1 nm, a stepwidth of 1 nm, and 1 sec averaging per point. The spectra were corrected using a reference solution without the protein. Typically a protein concentration of 10 μM in 20 mM phosphate pH 7.0 was used. To obtain spectra of the protein assembled on the water-air interface the solution was vigorously shaken for two minutes. For spectra of SC3 bound to a hydrophobic support, 130 nm unstabilized colloidal Teflon spheres (Dupont de Nemours, Geneva, Switzerland) in water were added to the solution, following a known procedure (2) . D) Binding to Teflon
The coating of Teflon (Norton Fluorplast B.V., Raamsdonksveer, The Netherlands) by "SC3 and IAA-SC3 was assessed essentially as described by Wδsten et al . (3) . Thoroughly cleaned (ref. 3) Teflon sheets were incubated
for 16 hours in 20 μg/ml 35S-labelled hydrophobin in water, followed by three washes with water for 10 minutes each. The amount of adsorbed 35S-labelled protein was determined by scintillation counting before and after hot SDS extrac- tion (2%; pH 1,5) and subsequent washes with water. EXAMPLE 1
Solutions were prepared of 200 μg/ml SC3 and IAA- SC3 , each in the buffer described under C) were shaken vigorously. Whereas a precipitate formed readily in case of SC3 , the solution containing IAA-SC3 remained clear. This indicates that the solution containing modified hydrophobin is effectively stabilized. EXAMPLE 2
Upon addition of colloidal Teflon IAA-SC3 folded to the of-conformation, as observed, with CD (thick solid line in the figure) . SC3 adsorbed to colloidal Teflon also has the α- conformation (dotted line) . Although CD-measurements showed that IAA-SC3 was unfolded in solution (thin line; even after shaking) , the refolding of IAA-SC3 on Teflon shows the high propensity of stabilized hydrophobin to refold at such hydrophobic surfaces . E2AMPLE 3
SC3 binds very strongly to Teflon. Even heating for 10 minutes at 100°C in 2% SDS barely reduces the amount of hydrophobin adsorbed to a Teflon sheet. With IAA-SC3 the observed reduction in bound radioactivity was 16% versus 10% for SC3. This indicates a strong binding of modified SC3 under the test conditions.
With atomic force-microscopy, a typical rodlet pattern is observed with a hydrophobin such as SC3 dried on a flat mica surface. This same pattern was observed with IAA- SC3 (data not shown) . EXAMPLE 4
Example 1 was repeated with S03-SC3. The protein was soluble in water and did assemble or aggregate, even after shaking the solution. The CD spectrum was characteristic for unfolded protein (result not shown) . E.2C.AMPLE 5
Following the conditions of example 2, it was
observed that S03-SC3 refolded at a Teflon surface, and CD showed the characteristic Q!-helical conformation (results not shown) . The refolding is thought to be beneficial for the formation of native disulphide bridges (cystin) . EXAMPLE 6
50% of radioactively labelled S03-SC3 bound to a Teflon surface remained bound after treatment with hot SDS at pH=7.0. At this pH, the sulphite groups of S03-SC3 are negatively charged. As a control, under the same conditions IAA- SC3 remained bound for 20% at this pH (84% remained bound at pH = 1.5) . This difference in binding can be attributed to the reversible derivatization of the sulfhydryl groups in SC3 and subsequent formation of disulfide bridges. That is, these results can be interpreted that at least part of the bound S03-SC3 is refolded and some of the S03 "-groups are removed, possibly by oxidation by oxygen present in the solution and resulting in the formation of disulphide bridges, resulting in a partial restoration of the original binding characteristics.
REFERENCES
1. Wessels, J.G.H. (1997) in Adv. Microb. Physiol. 38., pp. 1- 45.
2. De Vocht, M.L., et al . (1998) in Biophys. J. 74, pp. 2059- 68.
3. Wδsten, H.A.B., et al . (1994) in Embo. J. 13, pp. 5848-5
4. Wδsten, H.A.B.. et al . (1993) in Plant Cell 5, pp. 1567- 74.
5. Hollecker, M. (1989) in Protein Structure, ed. Creighton, T.E. (IRL Press, Oxford), pp. 145-53.
6. Chan W.W.C., (1968), Biochemistry, 7, pp. 4247-53.
Claims
1. Method of stabilizing a hydrophobin-containing solution, characterized in that the hydrophobin is subjected to a treatment with a disulphide bridge-cleaving agent to yield unfolded hydrophobin, said treatment involving the pre- vention of the formation of disulphide bridges from cleaved disulphide bridges.
2. Method according to claim 1, characterized in that the treatment consists of a treatment with sulphite, resulting in a modified hydrophobin carrying sulphite groups. 3. Method according to claim 1, characterized in that the disulphide bridge cleaving agent is a reducing agent, resulting in the modified hydrophobin carrying free sulfhydryl-groups .
4. Method according to claim 3, characterized in that the prevention of the formation of disulphide bridges comprises reacting the reduced hydrophobin with a sulfhydryl- protecting agent yielding hydrophobin having sulfhydryl- protecting groups.
5. Method according to claim 4, characterized in that the sulfhydryl-protecting agent is a protecting agent resulting in an ionic protecting group.
6. Method according to claim 4 or 5 , characterized in that the sulfhydryl-protecting agent is chosen to allow for removal of the sulfhydryl-protecting groups to yield free sulfhydryl residues.
7. Method according to any of the preceding claims, characterized in that the prevention of the formation of disulphide bridges comprises exposing the reduced hydrophobin to an environment in which substantially no oxidizing agent is present.
8. Method according to any of the preceding claims, characterized in that the treatment is performed in the presence of an agent chosen from the group consisting of a) a surfactant; and b) a chaotropic agent. 9. Method for coating a surface with a hydrophobin, characterized in that a stabilized hydrophobin-containing
solution according to any of the claims 1 to 8 is used, wherein the stabilized solution is contacted with a surface to be coated with the hydrophobin before the surface is contacted with an agent for the formation of disulphide bridges, and sulfhydryl-protecting residues, if present, are removed.
11. Method according to claim 10, characterized in that the agent is an oxydizing agent.
12. Method of coating a surface with a hydrophobin, characterized in that a stabilized hydrophobin-containing solution according to any of the claims 1 to 8 is used, wherein in the absence of a gaseous phase i) sulfhydryl-protecting groups, if present, are removed and ii) the reduced hydrophobin is contacted with an agent in the liquid phase before, during or after contacting the reduced hydrophobin with the surface to be coated.
13. Method according to claim 12, characterized in that the agent is an oxydizing agent.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0002660 | 2000-02-04 | ||
| GBGB0002660.9A GB0002660D0 (en) | 2000-02-04 | 2000-02-04 | Method of stabilizing a hydrophobin-containing solution and a method of coatinga surface with a hydrophobin |
| PCT/NL2001/000082 WO2001057066A2 (en) | 2000-02-04 | 2001-02-02 | Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001237794A1 true AU2001237794A1 (en) | 2001-08-14 |
Family
ID=9885024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001237794A Abandoned AU2001237794A1 (en) | 2000-02-04 | 2001-02-02 | Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20030113454A1 (en) |
| EP (1) | EP1254158B1 (en) |
| JP (1) | JP2003522182A (en) |
| AT (1) | ATE307138T1 (en) |
| AU (1) | AU2001237794A1 (en) |
| CA (1) | CA2399231A1 (en) |
| DE (1) | DE60114152T2 (en) |
| GB (1) | GB0002660D0 (en) |
| WO (1) | WO2001057066A2 (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1909979A (en) | 2004-01-16 | 2007-02-07 | 应用超微系统股份有限公司 | Method for coating an object with hydrophobin at low temperature |
| US7147912B2 (en) * | 2004-08-18 | 2006-12-12 | E. I. Du Pont De Nemours And Company | Amphipathic proteinaceous coating on nanoporous polymer |
| US7241734B2 (en) * | 2004-08-18 | 2007-07-10 | E. I. Du Pont De Nemours And Company | Thermophilic hydrophobin proteins and applications for surface modification |
| EP1848734A2 (en) * | 2005-02-07 | 2007-10-31 | Basf Aktiengesellschaft | Method for coating surfaces with hydrophobins |
| US7892788B2 (en) | 2005-02-07 | 2011-02-22 | Basf Se | Hydrophobin fusion products, production and use thereof |
| KR101250105B1 (en) * | 2005-03-30 | 2013-04-03 | 바스프 에스이 | Use of hydrophobins for the surface treatment of hardened mineral building materials, natural stone, artificial stone and ceramics |
| WO2006103215A1 (en) * | 2005-03-30 | 2006-10-05 | Basf Aktiengesellschaft | Use of hydrophobin for hard surface soil-repellent treatment |
| BRPI0607594A2 (en) * | 2005-03-31 | 2010-04-06 | Basf Ag | multi-layer composite or coated substrate, process for preparing same, and use of hydrophobins |
| MX270311B (en) | 2005-04-01 | 2009-09-23 | Basf Ag | Drilling fluid containing hydrophobin. |
| MX2007011955A (en) | 2005-04-01 | 2007-12-05 | Basf Ag | Use of hydrophobin as a phase stabiliser. |
| DE102005027039A1 (en) * | 2005-06-10 | 2006-12-21 | Basf Ag | Hydrophobin as a coating agent for expandable or expanded thermoplastic polymer particles |
| DE102005027139A1 (en) | 2005-06-10 | 2006-12-28 | Basf Ag | New cysteine-depleted hydrophobin fusion proteins, their production and use |
| DE102005029704A1 (en) * | 2005-06-24 | 2007-01-11 | Basf Ag | Use of hydrophobin polypeptides and conjugates of hydrophobin polypeptides with active or effect substances and their preparation and their use in cosmetics |
| DE102005048720A1 (en) * | 2005-10-12 | 2007-04-19 | Basf Ag | Use of proteins as an antifoam component in fuels |
| CN101501432B (en) * | 2006-08-15 | 2011-10-12 | 巴斯夫欧洲公司 | Method for the production of dry free-flowing hydrophobin preparations |
| US8226967B2 (en) | 2008-11-27 | 2012-07-24 | Basf Se | Surface active proteins as excipients in solid pharmaceutical formulations |
| EP2371844A1 (en) | 2010-03-25 | 2011-10-05 | B.R.A.I.N. Biotechnology Research and Information Network AG | Chimeric surface active proteins |
| WO2011101457A1 (en) | 2010-02-18 | 2011-08-25 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Chimeric surface active proteins |
| US20140031272A1 (en) | 2011-04-08 | 2014-01-30 | Danisco Us Inc. | Compositions |
| DE102011081524B4 (en) | 2011-08-24 | 2017-05-24 | Technische Universität Dresden | COATING OF SUBSTRATES WITH A MONOLAGE OF SELF-TEMPERATING PROTEINS |
| WO2013026919A1 (en) | 2011-08-24 | 2013-02-28 | Technische Universität Dresden | Method for coating substrates with at least one monolayer of self-assembling proteins |
| EP2909230B1 (en) | 2012-10-19 | 2019-05-22 | Danisco US Inc. | Stabilization of biomimetic membranes |
| CA2934039A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Use of hydrophobins to increase gas transferin aerobic fermentation processes |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7404589A (en) * | 1974-04-03 | 1975-10-07 | Stichting Rega V Z W | PROCEDURE FOR STABILIZING INTERFERON. |
| US4234561A (en) * | 1978-02-06 | 1980-11-18 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
| GB8618443D0 (en) * | 1986-07-29 | 1986-09-03 | Univ London | Monoclonal antibodies |
| JPH01238600A (en) * | 1987-11-26 | 1989-09-22 | Nippon Koutai Kenkyusho:Kk | Production of glycoprotein having anticancer property |
| US5130418A (en) * | 1989-05-02 | 1992-07-14 | California Biotechnology Inc. | Method to stabilize basic fibroblast growth factor |
| US5951972A (en) * | 1990-05-04 | 1999-09-14 | American Cyanamid Company | Stabilization of somatotropins and other proteins by modification of cysteine residues |
| AU644205B2 (en) * | 1990-08-23 | 1993-12-02 | New York Blood Center, Inc., The | Assays using a soluble fibrin-like monomer |
| JPH11507246A (en) * | 1996-03-20 | 1999-06-29 | ダイアックス コープ. | Designing affinity ligands for macromolecules |
| US6225061B1 (en) * | 1999-03-10 | 2001-05-01 | Sequenom, Inc. | Systems and methods for performing reactions in an unsealed environment |
-
2000
- 2000-02-04 GB GBGB0002660.9A patent/GB0002660D0/en not_active Ceased
-
2001
- 2001-02-02 AU AU2001237794A patent/AU2001237794A1/en not_active Abandoned
- 2001-02-02 AT AT01910214T patent/ATE307138T1/en not_active IP Right Cessation
- 2001-02-02 US US10/182,754 patent/US20030113454A1/en not_active Abandoned
- 2001-02-02 EP EP01910214A patent/EP1254158B1/en not_active Expired - Lifetime
- 2001-02-02 DE DE60114152T patent/DE60114152T2/en not_active Expired - Fee Related
- 2001-02-02 WO PCT/NL2001/000082 patent/WO2001057066A2/en not_active Ceased
- 2001-02-02 CA CA002399231A patent/CA2399231A1/en not_active Abandoned
- 2001-02-02 JP JP2001557897A patent/JP2003522182A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE60114152D1 (en) | 2006-03-02 |
| JP2003522182A (en) | 2003-07-22 |
| EP1254158A2 (en) | 2002-11-06 |
| ATE307138T1 (en) | 2005-11-15 |
| DE60114152T2 (en) | 2006-07-06 |
| CA2399231A1 (en) | 2001-08-09 |
| US20030113454A1 (en) | 2003-06-19 |
| EP1254158B1 (en) | 2005-10-19 |
| GB0002660D0 (en) | 2000-03-29 |
| WO2001057066A2 (en) | 2001-08-09 |
| WO2001057066A3 (en) | 2002-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1254158B1 (en) | Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin | |
| EP1257571B1 (en) | Method of purifying a hydrophobin present in a hydrophobin-containing solution | |
| US5663291A (en) | Process for obtaining insulin having correctly linked cystine bridges | |
| US5473049A (en) | Process for obtaining proinsulin possessing correctly linked cystine bridges | |
| RU2275377C2 (en) | Method for space packing chemically synthesized polypeptides | |
| Hunt et al. | Partial characterization of undegraded oat phytochrome | |
| Strazza et al. | The thermodynamics of bovine and porcine insulin and proinsulin association determined by concentration difference spectroscopy | |
| Ollivier et al. | A simple and traceless solid phase method simplifies the assembly of large peptides and the access to challenging proteins | |
| Jenson et al. | Physical-chemical properties of ubiquitin | |
| YUTANI et al. | The mechanism of refording of the reduced random coil form of lysozyme | |
| Engel et al. | Physical properties of the amino-terminal precursor-specific portion of type I procollagen | |
| Calabrese et al. | Purification and properties of bovine caeruloplasmin | |
| Bruschi et al. | Non-heme iron proteins The amino acid sequence of rubredoxin from Desulfovibrio vulgaris | |
| Bisaccia et al. | Transmembrane topography of the mitochondrial oxoglutarate carrier assessed by peptide-specific antibodies and enzymic cleavage | |
| Busse et al. | Synthesis and properties of carbonylbis (methionyl) insulin, a proinsulin analog which is convertible to insulin by cyanogen bromide cleavage | |
| Holman et al. | Extent of Proton Transfer in the Transition States of the Reaction Catalyzed by the. DELTA. 5-3-Ketosteroid Isomerase of Comamonas (Pseudomonas) testosteroni: Site-Specific Replacement of the Active Site Base, Aspartate 38, by the Weaker Base Alanine-3-sulfinate | |
| Coussons et al. | Transglutaminase catalyses the modification of glutamine side chains in the C-terminal region of bovine β-lactoglobulin | |
| US5049545A (en) | Insulin derivatives, a process for their preparation, and their use | |
| KR100944845B1 (en) | Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines | |
| AU624894B2 (en) | Process for the preparation of an insulin precursor | |
| Rau et al. | Biomimetic constructs. De‐novo design of redox proteins | |
| CA2008246A1 (en) | Process for renaturing incorrect recombinants of insulin precursor | |
| Berglund et al. | A Thioredoxin Induced by Bacteriophage T4: III. AMINO ACID SEQUENCE AROUND THE ACTIVE CENTER DISULFIDE | |
| JP2916205B2 (en) | Bioactive peptide | |
| Gielens et al. | Conformational stabilization at the active site of molluskan (Rapana thomasiana) hemocyanin by a cysteine–histidine thioether bridge: A study by mass spectrometry and molecular modeling |